title: Gender differences in self-reported use, perceived efficacy, and interest in future use of nicotine-dependence treatments: A cross-sectional survey in adults at a tertiary care center for nicotine dependence.
abstract: BACKGROUND
  Clinical trials have assessed the effectiveness of nicotine-dependence treatments (NDTs), alone or in combination, and reported that men and women have variable responses to these treatments. The variations in therapeutic responses highlight the need to explore gender-specific preferences for NDTs, including complementary and alternative medicine (CAM), which has become increasingly popular in the US population for the cessation of tobacco use.
  
  
  OBJECTIVE
  The aim of this study was to assess gender differences in the self-reported use, perceived efficacy, and interest in future use of NDTs, including CAM, in an outpatient setting.
  
  
  METHODS
  This cross-sectional survey was conducted in men and women at a tertiary care NDT clinic. The primary inclusion criterion was the willingness and ability of the patients to participate in the survey.
  
  
  RESULTS
  Data from 1171 patients were included (599 men, 572 women; mean age: men, 46.2 years; women, 46.5 years). Of these, 68% of women and 65% of men reported use of nicotine-replacement therapy (NRT), other prescription medication, or counseling/group support. In men and women, NRT was the most commonly used type of pharmacologic treatment, of which the patch was the most popular (77% and 75%). A significantly greater proportion of women than men perceived the nicotine inhaler to be efficacious (67% vs 50%; P = 0.027). No other significant gender differences were found among NRTs. Among non-NRT methods, bupropion sustained release (SR) and counseling/group support were used by significantly more women than men (53% vs 43% [P = 0.007] and 16% vs 11% [P = 0.026], respectively). Compared with men, significantly greater proportions of women reported current or previous use of CAM for nicotine abstinence and expressed an interest in future use of CAM (34% vs 22% [P < 0.001] and 71% vs 64% [P = 0.006]).
  
  
  CONCLUSIONS
  In this sample of patients at an NDT clinic, significantly more women than men reported previous use of bupropion SR, counseling, and CAM. More women than men expressed an interest in the future use of CAM. Based on these findings, an improved understanding of gender-based differences in the use of conventional and nonconventional NDTs might improve the rates of success of nicotine-cessation efforts among women.
authors.affiliation: Mayo Clinic College of Medicine, Rochester, Minnesota, USA. sujata.narayanan@hsc.utah.edu
authors.forename: Sujata
authors.initials: S
authors.lastname: Narayanan
authors.forename: Jon O
authors.initials: JO
authors.lastname: Ebbert
authors.forename: Amit
authors.initials: A
authors.lastname: Sood
mesh_terms: D000554:Ambulatory Care Facilities; D000928:Antidepressive Agents / Q000627:therapeutic use; D018678:Cholinergic Agents / Q000627:therapeutic use; D000529:Complementary Therapies / Q000706:statistics & numerical data; D003430:Cross-Sectional Studies; D019587:Dietary Supplements; D037001:Directive Counseling / Q000706:statistics & numerical data; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006306:Health Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D018722:Nicotinic Agonists / Q000627:therapeutic use; D057240:Patient Preference; D012737:Sex Factors; D012907:Smoking / Q000188:drug therapy / Q000628:therapy*; D016540:Smoking Cessation / Q000379:methods*; D016320:Substance Abuse Treatment Centers
chemical_list: D000928:Antidepressive Agents; D018678:Cholinergic Agents; D018722:Nicotinic Agonists